Art

J-GLOBAL ID：201802277076555087   Reference number：18A1593586

A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)

進行胃癌に対するファーストライン治療としてのカペシタビン+シスプラチン対S-1+シスプラチンの無作為化第II相試験: カペシタビン+シスプラチンastainment対S-1+シスプラチン無作為化PII試験(XPARTII)【JST・京大機械翻訳】

Author (24)： Nishikawa Kazuhiro (Department of Surgery, Osaka National Hospital, Osaka, Japan) ,  Tsuburaya Akira (Department of Surgery, Tsuboi Cancer Center Hospital, Koriyama, Japan) ,  Yoshikawa Takaki (Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan) ,  Kobayashi Michiya (Department of Human Health and Medical Science, Kochi Medical School, Nankoku, Japan) ,  Kawada Junji (Department of Surgery, Osaka General Medical Center, Osaka, Japan) ,  Fukushima Ryoji (Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan) ,  Matsui Takanori (Department of Surgery, Aichi Cancer Center Aichi Hospital, Okazaki, Japan) ,  Tanabe Kazuaki (Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan) ,  Yamaguchi Kazuya (Department of Surgical Oncology, Gifu University, Gifu, Japan) ,  Yoshino Shigefumi (Oncology Center, Yamaguchi University Hospital, Ube, Japan) ,  Takahashi Masazumi (Division of Gastroenterological Surgery, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan) ,  Hirabayashi Naoki (Department of Surgery, Hiroshima City Asa Hospital, Hiroshima, Japan) ,  Sato Seiji (Department of Gastroenterological Surgery, Saga-Ken Medical Center Koseikan, Saga, Japan) ,  Nemoto Hiroshi (Department of Surgery, Ebina General Hospital, Ebina, Japan) ,  Rino Yasushi (Department of Surgery, Yokohama City University, Yokohama, Japan) ,  Nakajima Junta (Department of 3rd Internal Medicine, Obihiro-Kosei General Hospital, Obihiro, Japan) ,  Aoyama Toru (Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan) ,  Miyagi Yohei (Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan) ,  Oriuchi Noboru (Advanced Clinical Research Center, Fukushima Medical University, Fukushima, Japan) ,  Yamaguchi Kensei (Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Miyashita Yumi (Epidemiological & Clinical Research Information Network (ECRIN), Okazaki, Japan) ,  Morita Satoshi (Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Sakamoto Junichi (Epidemiological & Clinical Research Information Network (ECRIN), Okazaki, Japan) ,  Sakamoto Junichi (Tokai Central Hospital, Kakamigahara, Japan)
Material： European Journal of Cancer  (Eur J Cancer)
Volume： 101  Page： 220-228  Publication year： 2018 
JST Material Number： A0802C  ISSN： 0959-8049  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Capecitabine plus cisplatin (X...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1593586&from=J-GLOBAL&jstjournalNo=A0802C") }}

Thesaurus term： Japan ,  patient ,  *therapy ,  *phase 2 study ,  Safety ,  phase 3 study ,  Anemia ,  median value ,  anorexia ,  Neutropenia ,  end point ,  *Advanced gastric cancer ,  *platinum complex ,  *antitumor drug ,  *ammine complex ,  *chloro complex ,  adverse reaction
Semi thesaurus term： *cisplatin ,  有害事象 ,  レジメン , 【Automatic Indexing@JST】

Author keywords (5)： Advanced gastric cancer ,  First-line chemotherapy ,  Capecitabine plus cisplatin (XP) ,  S-1 plus cisplatin (SP) ,  Histological subtypes

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of digestive system  (GH04000D)

Terms in the title (6)： 進行胃癌 ,  治療 ,  カペシタビン ,  シスプラチン ,  第II相試験 ,  試験